Samuel Mon-Wei Yu, John Cijiang He

6
Oct 5, 2021
Cell metabolism
DOI :
10.1016/j.cmet.2021.08.019
show_chart

In a new study, Zhu et al. (2021) show that mitigating dysbiosis by the probiotic L. casei Zhang reduces kidney inflammation via restoring short-chain fatty acid-producing gut microbiome and nicotinamide metabolism. These findings shed light on the underlying mechanisms of probiotics in treating human kidney diseases.
Please Log In to leave a comment.